Remedent, Inc.
REMI
$0.05
$0.000.00%
| 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 3.47% | 28.77% | 32.96% | -29.32% | -242.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.47% | 28.77% | 32.96% | -29.32% | -242.09% |
| Cost of Revenue | 1.16% | 35.73% | 66.57% | -13.64% | -222.88% |
| Gross Profit | 4.28% | 24.78% | 19.92% | -34.51% | -250.14% |
| SG&A Expenses | 123.69% | -32.07% | -44.87% | -52.68% | -139.24% |
| Depreciation & Amortization | -34.74% | -47.90% | -53.40% | -52.23% | -59.57% |
| Other Operating Expenses | 17.54% | -- | -- | -- | -- |
| Total Operating Expenses | 40.09% | -16.10% | -23.04% | -44.68% | -225.03% |
| Operating Income | -138.52% | 111.71% | 163.52% | 115.63% | 194.55% |
| Income Before Tax | -124.79% | 162.38% | 101.30% | 104.40% | -83.92% |
| Income Tax Expenses | -110.00% | 41.18% | -- | -- | -- |
| Earnings from Continuing Operations | -124.22% | 160.26% | 101.30% | 104.40% | -83.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 844.44% | -126.35% | -81.44% | 75.89% | 109.28% |
| Net Income | -122.11% | 163.64% | 102.51% | 100.58% | -83.78% |
| EBIT | -138.52% | 111.71% | 163.52% | 115.63% | 194.55% |
| EBITDA | -132.38% | 121.73% | 190.70% | 147.43% | 211.91% |
| EPS Basic | 126.11% | 163.51% | 102.50% | 101.04% | -114.11% |
| Normalized Basic EPS | -- | 169.77% | 104.17% | 98.44% | -- |
| EPS Diluted | 123.50% | 147.00% | 102.00% | 101.04% | -115.67% |
| Normalized Diluted EPS | -- | 169.77% | 104.17% | 98.44% | -- |
| Average Basic Shares Outstanding | -- | 0.00% | 0.00% | 0.00% | -- |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
